Navigation Links
Blue Dye Test Alternative Installed at Bayer China for Packaging Quality Assurance Process
Date:10/24/2009

A blue dye test alternative using innovative laser technology has been installed at the fastest pharmaceutical packaging line in Asia Pacific as part of their quality assurance processes. Bayer China has acquired Sepha’s ‘BlisterScan’ machines for non-destructive leak testing on a wide variety of blisterpacks containing tablets and capsules.

Belfast (Vocus) October 22, 2009 -- Quality assurance leak testing equipment supplied by the packaging specialist, Sepha, has been installed at Bayer China, home to the fastest pharmaceutical packaging line in Asia Pacific. BlisterScan is a non-destructive method of quality control which tests for leaks in blisterpacks using state-of-the-art non contact technology.

Sepha Chief Executive Aubrey Sayers explains: “Testing is a vital part of quality assurance for pharmaceutical manufacturers to ensure package integrity, drug stability and minimise waste. BlisterScan gives a snap shot of the quality of the packaging of batches. It replaces the traditional and messy blue-dye test method of checking for leaks using a liquid test that rendered the packs and their contents un-useable regardless of whether they have a hole in them or not. BlisterScan can detect leaks as small as 7 microns in individual blister pockets using scanning technology. So all samples which ‘pass’ the test can be re-introduced to the packaging line, thus reducing waste and increasing productivity.”

BlisterScan instantly pinpoints the location of a faulty pocket seal by using a beam of light that scans the pockets before and after applying a vacuum. A pass or fail result is given on the basis of the ‘before’ and ‘after’ reading against predetermined leakage acceptance levels and from the results a correlation with the hole size can be made. No specialist knowledge or training is required to use the machine and the test cycle is complete in less than six minutes with tooling changeover taking about 30 seconds.

Sepha will be demonstrating BlisterScan’s benefits to other China-based pharma companies at China Pharm, in Shanghai from 27-30 October when they will be exhibiting in partnership with its agent Rieckermann Pharmatech Ltd. who are celebrating 10 years in business at the show. Visitors are invited to join them in the celebrations in Hall W5, Booth 5401.

Sepha’s extensive technical expertise within the pharmaceutical industry has resulted in close working relationships with a large number of the world’s top pharmaceutical manufacturers. Their machines have been developed to meet the stringent standards that pharmaceutical companies face in highly competitive and regulated markets. In addition to BlisterScan, the range includes ‘PakScan’: a leak tester for non-destructive testing of pouches and sachets, as well as ‘PressOut’ deblistering devices which transform the laborious task of removing tablets from their capsules into an automated process as fast as 50 tablets per minute.

###

Read the full story at http://www.prweb.com/releases/Sepha/BlisterScan/prweb3090194.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Blue Dye Test Alternative Boosts Production Yields During Tough Times
2. Karl Strauss and GreenHouse Partner to Create Alternative Fuel from Beer Waste
3. Elsevier Releases Results of Alternative Energy Research Leadership Study Identifying Top 25 Institutions Worldwide
4. Xmark Requests That Icagen Oust Its CEO and Pursue Strategic Alternatives, and Calls on Board Members to Resign
5. Just Say No To Charcoal! New Eco-Friendly Alternative Grills Faster, Burns Cleaner And Greener
6. VIASPACE Inc. Alternative Energy Business Covered in Research Report
7. Syndication Inc. Seeks DIRECTOR OF TECHNICAL ENGINEERING for PINNACLE ENERGY - Its New Alternative Energy Subsidiary
8. CTI Seeks Strategic Alternative for Italian Facility
9. Secretropin(R) - Effective, Preferable, Affordable as an Alternative to Injectable Growth Hormone - Gains Momentum
10. Quest PharmaTech Announces a Review of Strategic Alternatives to Enhance Shareholder Value
11. XTL Biopharmaceuticals Provides Update on Potential Strategic Alternatives
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blue Dye Test Alternative Installed at Bayer China for Packaging Quality Assurance Process
(Date:2/27/2017)... HAMILTON, Bermuda , Feb. 27, ... ADXS ) and SELLAS Life Sciences ... developing cancer immunotherapies, today announced that Advaxis has ... cancer immunotherapy agent using Advaxis, proprietary Lm ... targeted heteroclitic peptide antigen mixture (galinpepimut-S). ...
(Date:2/25/2017)... ... February 25, 2017 , ... The STARR Coalition ... effort to create meaningful change by increasing communication, partnerships and goodwill among stakeholders ... and patients’ mental health well-being. , Both organizations are dedicated to promoting patient ...
(Date:2/24/2017)... , Feb. 24, 2017  Aethlon Medical, Inc. (Nasdaq: ... authored by its Chairman and CEO, Jim Joyce ... Munich Security Conference last Saturday, Bill Gates ... kill more people than nuclear weapons. Mr. Gates expressed ... U.K. intelligence agencies, that scientific terrorists have access to ...
(Date:2/24/2017)... China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the ... today announced its financial results for the fourth quarter and ... Financial Highlights Total sales in the ... or increased by 13.6% in USD terms to $77.6 million ... Gross profit increased by 13.3% to $46.8 million ...
Breaking Biology Technology:
(Date:2/13/2017)... 13, 2017 Former 9/11 Commission border counsel ... Janice Kephart of Identity Strategy Partners, LLP, ... Trump,s "Executive Order: Protecting the Nation From Foreign ... "As President Trump,s ,Travel Ban, Executive Order ... essentially banned the travel ban, it is important that ...
(Date:2/8/2017)... 7, 2017  Aware, Inc. (NASDAQ: AWRE ), ... financial results for its quarter and year ended December 31, ... 2016 was $3.9 million compared to $6.9 million in the ... of 2016 was $0.6 million compared to $2.6 million in ... quarter of 2016 was $0.5 million, or $0.02 per diluted ...
(Date:2/7/2017)... Feb. 7, 2017   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce that ... its innovative, highly flexible and award winning eClinical solution, ... iMedNet is a proven Software-as-a-Service (SaaS) clinical ... Capture (EDC), but also delivers an entire suite of ...
Breaking Biology News(10 mins):